Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML

Clinical trial NCT03727750 · COMPLETED

Trial details

NCT number: NCT03727750
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

ECG Pharmacokinetics Safety

Start date: 2019-07-03
Primary completion: 2021-04-27
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.